Literature DB >> 12145588

New technique for optical control of the first trocar insertion.

R Lombezzi1, R Galleano, L Lucarini, F Falchero.   

Abstract

BACKGROUND: In laparoscopic surgery serious complications caused by the blind insertion of the first trocar have been reported even after the pneumoperitoneum is established by means of a Veress needle. As a consequence, some techniques to safely insert the first port have been developed. Many surgeons advocate a minilaparotomy to position the first port. However, especially in obese patients, the dissection to insert the Hasson's trocar may be difficult and time consuming. As an alternative, optical disposable trocars have been studied and produced to be safely positioned under direct visualization.
METHODS: A new technique to insert, under adequate optical control, a non disposable standard port is described. Personal experience in 126 consecutive patients is reviewed. Data were recorded prospectically and insertion time was recorded in every case.
RESULTS: Medium time of trocar insertion was 55 sec (range 30-160 sec). Identification of distinct layers of the abdominal wall was always possible. There were no complications related to the insertion of the first reusable cannula under visual control.
CONCLUSIONS: This technique may be considered a safe, simple and cost effective method to insert the first trocar.

Entities:  

Mesh:

Year:  2002        PMID: 12145588

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  2 in total

1.  Experience with the optical access trocar for safe and rapid entry in the performance of laparoscopic gastric bypass.

Authors:  Barry R Berch; Alfonso Torquati; Rami Edward Lutfi; William O Richards
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

Review 2.  Laparoscopic entry techniques: clinical guideline, national survey, and medicolegal ramifications.

Authors:  Rajesh Varma; Janesh K Gupta
Journal:  Surg Endosc       Date:  2008-04-10       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.